Aesthetic practices across the U.S. are reporting a surge in demand for combination treatments targeting "Ozempic face"—the hollowed, aged appearance caused by rapid weight loss from GLP-1 receptor agonists. Practices are bundling Botox or Dysport with volumizing fillers, biostimulators, and facial treatments to address dynamic lines, structural volume loss, and skin quality simultaneously.
Market
"Ozempic Face" Facials Driving Botox Boom—Practices Capitalize on GLP-1 Side Effect
Practices are bundling neuromodulators, fillers, and skin treatments to address volume loss in GLP-1 patients.
1-YEAR MOVE
ABBV
▲11.6%
EOLS
▼15.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
| EOLS | Evolus | −15.6% |
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
GLP-1 patients seeking facial rejuvenation are driving higher per-patient treatment frequency and bundled protocols.
This trend is driving higher average transaction values and increased per-patient visit frequency. Practices with strong filler inventory, trained staff in combination protocols, and clear before-and-after galleries showcasing Ozempic face transformations are capturing disproportionate share of this demographic. The phenomenon also highlights the importance of having robust supply agreements with manufacturers—Allergan, Galderma, and Evolus are all seeing elevated demand from practices serving this patient cohort.
Source: original report ↗
Frequently asked questions
What is Ozempic face and why does it happen?
Ozempic face refers to the hollowed, aged appearance caused by rapid weight loss from GLP-1 receptor agonists like Ozempic and Wegovy. The drugs suppress appetite and accelerate fat loss, including facial fat that normally provides volume and structure, leaving patients with sunken cheeks, deeper nasolabial folds, and sagging skin.
What treatments are practices bundling to fix Ozempic face?
Practices are combining neuromodulators (Botox or Dysport) with volumizing fillers, biostimulators, and facial treatments in single sessions. This multi-modal approach addresses dynamic lines, restores structural volume loss, and improves overall skin quality simultaneously for faster, more comprehensive results.
How much are practices charging for Ozempic face treatment bundles?
While specific pricing wasn't disclosed, practices report significantly higher average transaction values and increased per-patient visit frequency by bundling these treatments compared to standalone procedures. Combination protocols with fillers, neuromodulators, and biostimulators command premium pricing due to the complexity and multiple products involved.
Which filler brands are seeing the most demand from Ozempic face treatments?
Allergan, Galderma, and Evolus are all experiencing elevated demand from practices serving GLP-1 patients. Practices with strong filler inventory and robust supply agreements with these manufacturers are best positioned to capitalize on the Ozempic face trend.
What should practices do to capture Ozempic face patients?
Build strong filler inventory, train staff in combination treatment protocols, secure reliable supply agreements with major manufacturers, and create clear before-and-after galleries specifically showcasing Ozempic face transformations. Practices with these assets are capturing a disproportionate share of this high-value patient demographic.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.